Becton Dickinson in $60 Million Multistate Settlement on Pelvic Mesh Products
September 24 2020 - 3:15PM
Dow Jones News
By Michael Dabaie
Becton Dickinson & Co. said attorneys general from 48 states
and the District of Columbia unveiled a $60 million settlement with
the company to resolve legacy litigation from C.R. Bard.
Medical technology company Becton said the litigation was
initiated prior to its acquisition of Bard in 2017 and related to
discontinued pelvic mesh products.
A statement from Connecticut Attorney General William Tong said
the attorneys general allege that C.R. Bard misrepresented or
failed to adequately disclose serious and life-altering risks of
surgical mesh devices, such as chronic pain, scarring and shrinking
of bodily tissue, painful sexual relations, and recurring
infections, among other complications.
Becton said the company and Bard have denied any wrongdoing and
all allegations included in the litigation and chose to settle the
matter to avoid the time and expense of further litigation. The
company said it is fully reserved for the settlement amount.
Becton Dickinson shares were down 2% to $221.34 in afternoon
trading.
Write to Michael Dabaie at michael.dabaie@wsj.com
(END) Dow Jones Newswires
September 24, 2020 15:00 ET (19:00 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From Apr 2023 to Apr 2024
